etoposide has been researched along with g(m3) ganglioside in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Igarashi, Y; Inokuchi, J; Kabayama, K; Kang, BW; Noguchi, M; Saito, M; Uemura, S | 1 |
Azuma, Y; Higai, K; Matsumoto, K; Sato, H | 1 |
2 other study(ies) available for etoposide and g(m3) ganglioside
Article | Year |
---|---|
Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Lewis Lung; Caspase 3; Caspase 9; Caspase Inhibitors; Ceramides; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; G(M3) Ganglioside; Mice; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Up-Regulation | 2006 |
Enhanced expression of membrane-associated sialidase Neu3 decreases GD3 and increases GM3 on the surface of Jurkat cells during etoposide-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Survival; Enzyme Activation; Enzyme Inhibitors; Etoposide; G(M3) Ganglioside; Gangliosides; Humans; Jurkat Cells; Lectins; Neuraminidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase II Inhibitors | 2007 |